The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy

por Hui Yang, Kunlun Wang, Bingxu Li, Bingxu Li, Shenglei Li, Yan Li, Ling Yuan
Publicado 2021

c‐Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR‐145‐5p/SPOP/PD‐L1 axis

por Lan Zhang, Xiaohui Wang, Yunfei Li, Jing Han, Xianzheng Gao, Shenglei Li, Feng Wang
Publicado 2021